Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “expansion”

21 pharma patents match "expansion" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 21
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 21 pharmaceutical patents matching "expansion" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

21 results for “expansion” · 30,257 patents in full index Clear search

  1. US 12343380

    Expansion of TILs utilizing AKT pathways inhibitors

    Iovance Biotherapeutics, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  2. US 12031157

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  3. US 12024718

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  4. US 11981921

    TIL expansion processes using specific cytokine combinations and/or AKTi treatment

    Iovance Biotherapeutics, Inc. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  5. US 11866688

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  6. US 11667890

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  7. US 11401506

    Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy

    Board nf Regents The Inivercitvof Texas Cvctom · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  8. US 11384337

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted
  9. US 11357841

    Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof

    Iovance Biotherapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  10. US 10760076

    Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion

    ProQR Therapeutics II B.V. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  11. US 10709812

    Biodegradable hydrogel for tissue expansion

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted
  12. US 10415015

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted
  13. CA 3091946

    EXPANSION ET DIFFERENCIATION DE CELLULES SOUCHES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Sep 6, 2019 · Expires Sep 1, 2039

    granted
  14. US 9976138

    Methods and compounds useful in conditions related to repeat expansion

    Ionis Pharmaceuticals, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  15. US 9801911

    Expansion of alloantigen-reactive regulatory T cells

    The Regents of the University of California · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  16. US 9700583

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  17. US 9095562

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted
  18. US 7368106

    Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  19. US 7175838

    Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

    The United States of America represented by the Department of Health and Human Services · Granted Feb 13, 2007 · Expires Feb 8, 2027

    granted
  20. US 6642049

    Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells

    United States of America as represented by the Secretary of the Air Force · Granted Nov 4, 2003 · Expires Oct 30, 2023

    expired
  21. US 6291652

    Antibodies specific for proteins having polyglutamine expansions

    The Regents of the University of California · Granted Sep 18, 2001 · Expires Sep 13, 2021

    expired